Evidence map›Paper›PMID 42414485›Full record

ArticleScientific reports2026

Retraction Note: Liposome co-incubation with cancer cells secreted exosomes (extracellular vesicles) with different proteins expressions and different uptake pathways.

Sherif E Emam, Hidenori Ando, Amr S Abu Lila, Taro Shimizu, Keiichiro Okuhira, Yu Ishima, Mahmoud A Mahdy, Fakhr-Eldin S Ghazy, Ikuko Sagawa, Tatsuhiro Ishida

Abstract readRetraction Notice
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Sherif E EmamDepartment of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University, 1-78-1 Sho-Machi, Tokushima, 770-8505, Japan.
Hidenori AndoDepartment of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University, 1-78-1 Sho-Machi, Tokushima, 770-8505, Japan.
Amr S Abu LilaDepartment of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University, 1-78-1 Sho-Machi, Tokushima, 770-8505, Japan.ORCID https://orcid.org/0000-0001-7385-868X
Taro ShimizuDepartment of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University, 1-78-1 Sho-Machi, Tokushima, 770-8505, Japan.
Keiichiro OkuhiraDepartment of Molecular Physical Pharmaceutics, Institute of Biomedical Sciences, Tokushima University, 1-78-1 Sho-Machi, Tokushima, 770-8505, Japan.
Yu IshimaDepartment of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University, 1-78-1 Sho-Machi, Tokushima, 770-8505, Japan.
Mahmoud A MahdyDepartment of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt.
Fakhr-Eldin S GhazyDepartment of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt.
Ikuko SagawaSupport Center for Advanced Medical Sciences, Institute of Biomedical Sciences, Tokushima University, 1-78-1 Sho-Machi, Tokushima, 770-8505, Japan.
Tatsuhiro IshidaDepartment of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University, 1-78-1 Sho-Machi, Tokushima, 770-8505, Japan. ishida@tokushima-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42414485
PMCPMC13342257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.